A 12-week prospective cohort enrolled 73 patients with guideline-based asthma or COPD and no speech-affecting comorbidities, ...

The introduction of biologic therapies for severe asthma has transformed clinical practice. Among these agents, benralizumab ...

The introduction of respiratory biologics shows greatest benefits in patients with severe and eosinophilic asthma.

Infections, not eosinophilic inflammation, are the primary cause of asthma exacerbations in patients receiving benralizumab.

In one phase 3 trial, former smokers with COPD receiving itepekimab had a significantly lower annualized moderate/severe ...

Getting an asthma diagnosis means you have to learn some new lingo. Your doctor may throw around phrases like “peak flow readings” (a way to measure how well your lungs are functioning), “short-acting ...

Key TakeawaysVoice changes measured by a smartphone app can predict oncoming asthma or COPD flaresPeople’s voices change ...

A research team from the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has highlighted recent advances in understanding and managing COPD, particularly in relation to its ...

Retrospective studies have shown that statins decrease the rate and severity of exacerbations, the rate of hospitalization, and mortality in chronic obstructive pulmonary disease (COPD). We ...

The odds for asthma exacerbation and moderate to severe asthma in pediatric patients with asthma and allergy did not ...